A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema

NCT05121376 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema
HAE

Interventions

GENETIC: Dose 1 of BMN 331
GENETIC: Dose 2 of BMN 331
GENETIC: Dose 3 of BMN 331
GENETIC: Dose 4 of BMN 331
GENETIC: Dose 5 of BMN 331
GENETIC: Dose 6 of BMN 331
GENETIC: Dose 7 of BMN 331

Sponsor

BioMarin Pharmaceutical